The move follows the cancellation of roughly $400 million in funding for Columbia and the suspension of $175 million for the ...

The statistically significant responder analysis results for Mytesi® (crofelemer) in the OnTarget study's prespecified ...

In addition to its scientific sessions, PathAI will host H&E by the Sea, an AI-powered pathology networking event on March 25 th at 6:00 p.m. ET at the Nautilus Pier 4. The event will bring together ...

While many students kept to business as usual on Harvard Yard, community members, particularly professors, focused on ...

“We are pleased to be sharing several new analyses relating to aficamten at the upcoming ACC Scientific Session & Expo,” said ... of Aficamten in Healthy Participants (1091-139) Poster Presentation, ...

Background The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation associated with adverse ...

The FDA approved Kerendia in July 2021 for adults with chronic kidney disease associated with Type 2 diabetes to reduce the ...

Eisai Inc. announced today that the company will present the latest findings from its robust neurology portfolio, including data on real-world experience and continued maintenance dosing with our dual ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an ...

The so-called Abundance movement has become all the rage on the left. But its origin story is uniquely rooted in San ...

Originally, the Trump administration said that Usha Vance, the second lady, and Michael Waltz, the national security adviser, ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of ...